Abstract:The integration of diagnosis and therapy into one nanoplatform, known as theranostics, has attracted increasing attention in the biomedical areas. Herein, we first present a cancer cell targeting imaging and drug delivery system based on engineered thioether-bridged periodic mesoporous organosilica nanoparticles (PMOs). The PMOs are stably and selectively conjugated with near-infrared fluorescence (NIRF) dye Cyanine 5.5 (Cy5.5) and anti-Her2 affibody on the outer surfaces to endow them with excellent NIRF imaging and cancer targeting properties. Also, taking the advantage of the thioether-group-incorporated mesopores, the release of chemotherapy drug doxorubicin (DOX) loaded in the PMOs is responsive to the tumor-related molecule glutathione (GSH). The drug release percentage reaches 84.8% in 10 mM of GSH solution within 24 h, which is more than 2-fold higher than that without GSH. In addition, the drug release also exhibits pH-responsive, which reaches 53.6% at pH 5 and 31.7% at pH 7.4 within 24 h. Confocal laser scanning microscopy and flow cytometry analysis demonstrate that the PMOs-based theranostic platforms can efficiently target to and enter Her2 positive tumor cells. Thus, the smart imaging and drug delivery nanoplatforms induce high tumor cell growth inhibition. Meanwhile, the Cy5.5 conjugated PMOs perform great NIRF imaging ability, which could monitor the intracellular distribution, delivery and release of the chemotherapy drug. In addition, cell viability and histological assessments show the engineered PMOs have good biocompatibility, further encouraging the following biomedical applications. Over all, the systemically engineered PMOs can serve as a novel cancer cell targeting imaging and drug delivery platform with NIRF imaging, GSH and pH dual-responsive drug release, and high tumor cell targeting ability.

Enhancing silicon quantum dot uptake by pancreatic cancer cells via pluronic® encapsulation and antibody targeting

Versatile "click chemistry" approach to functionalizing silicon quantum dots: applications toward fluorescent cellular imaging.

Imaging Pancreatic Cancer Using Surface-Functionalized Quantum Dots.

Silicon Quantum Dots Delivered Phthalocyanine for Fluorescence Guided Photodynamic Therapy of Tumor

Stealth-like Polysarcosine-Modified Nanoparticles with Low Dye Doses and Long Blood Circulation for Efficient Breast Cancer Pulmonary Metastasis Imaging

Water-Soluble Silicon Quantum Dots toward Fluorescence-Guided Photothermal Nanotherapy

One-pot Synthesis of Silicon Based Nanoparticles with Incorporated Phthalocyanine for Long-Term Bioimaging and Photo-Dynamic Therapy of Tumors.

Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.

Polycation Fluorination Improves Intraperitoneal Sirna Delivery in Metastatic Pancreatic Cancer

Water-Soluble Chitosan-Quantum Dot Hybrid Nanospheres Toward Bioimaging and Biolabeling

Co-loading of Photothermal Agents and Anticancer Drugs into Porous Silicon Nanoparticles with Enhanced Chemo-Photothermal Therapeutic Efficacy to Kill Multidrug-Resistant Cancer Cells.

In vivo cancer targeting and imaging with semiconductor quantum dots

Drug delivery particles for targeted imaging-guided photothermal/chemotherapy synergy cancer therapy

Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells.

Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy

Diselenium-containing ultrathin polymer nanocapsules for highly efficient targeted drug delivery and combined anticancer effect

In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles.

Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents

A General Strategy to Encapsulate Semiconducting Polymers Within PEGylated Mesoporous Silica Nanoparticles for Optical Imaging and Drug Delivery

Scutellarin-loaded pH/H2O2 dual-responsive polymer cyclodextrin mesoporous silicon framework nanocarriers for enhanced cancer therapy

Development of Biodegradable GQDs-hMSNs for Fluorescence Imaging and Dual Cancer Treatment via Photodynamic Therapy and Drug Delivery